World's First Plant-Based COVID-19 Vaccine

Covifenz, jointly developed by Canada's Medicago and British pharma giant GlaxoSmithKline, has become the world's first plant-derived Covid vaccine to get approval. The two-dose vaccine, approved by Health Canada, uses Coronavirus-Like Particle or CoVLP technology. The Government of Canada has a contract with Medicago, which is affiliated to Mitsubishi Tanabe Pharma Corp., to supply the vaccine.